
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.
FOR IMMEDIATE RELEASE.
RECOMMENDED ACQUISITION
of
by
(a wholly-owned indirect subsidiary of
to be implemented by means of a scheme of arrangement
pursuant to Part 26 of the Companies Act 2006
COURT SANCTION OF SCHEME OF ARRANGEMENT
On
The scheme document in relation to the Scheme, including the notices convening the Court Meeting and the General Meeting, together with the associated Forms of Proxy, in connection with the Acquisition was published, posted and made available to Epwin Shareholders (other than to Epwin Shareholders in Restricted Jurisdictions) on
On
Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Scheme Document. All references to times in this announcement are to
Sanction of the Scheme
The Epwin Board and the Laumann
All of the Conditions of the Acquisition (as set out in Part III of the Scheme Document) have been satisfied or waived other than the delivery of a copy of the Court Order to the Registrar of Companies. The Scheme will become Effective upon the delivery of a copy of the Court Order to the Registrar of Companies for registration, which is expected to occur on
Next steps and timetable
There has been no change to the expected timetable of principal events for the Acquisition as set out in the announcement made by
It should be noted that the last day of dealings in, and for registration of transfers of, and disablement in CREST of, Epwin Shares will be
Dealings in Epwin Shares on AIM will be suspended from
It is further expected that, subject to the Scheme becoming Effective on
A further announcement will be made when the Scheme becomes Effective.
The expected timetable of principal events for the implementation of the Scheme remains as set out in the Scheme Document. If any of the key dates and/or times set out in this expected timetable change, the revised dates and/or times will be notified to Epwin Shareholders by issuing an announcement through a
Advisers
Enquiries:
Laumann and Laumann
|
|
|
+44 (0)207 839 3355 |
|
Via MHP |
|
+44 (0)207 408 4090 |
|
+44 (0)203 829 5000 |
MHP (
|
+44 (0)7885 447944 |
The person responsible for arranging the release of this announcement on behalf of
Financial advisers
Disclosure requirements of the Code
Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than
Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than
If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.
Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).
Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Panel's website at www.thetakeoverpanel.org.uk/disclosure/disclosure-table, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.
Publication on websites and availability of hard copies
Pursuant to Rule 26.1 of the Code, a copy of this announcement will be available free of charge, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, at Laumann's and
For the avoidance of doubt, the content of the websites referred to above is not incorporated into and does not form part of this announcement.
Copies of this announcement and all future documents, announcements and information required to be sent to persons in relation to the Acquisition may be requested to be received by such persons in hard copy form by writing to MUFG Corporate Markets,
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the